THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THIS WARRANTSenesco Technologies Inc • May 5th, 2005 • Services-commercial physical & biological research • New York
Senesco Technologies, Inc., a Delaware corporation (the “Company”), for value received, hereby certifies that [ ], or its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before 5:00 p.m. (New York time) on May [ ], 2010, [ ] shares of Common Stock, $0.01 par value per share, of the Company (“Common Stock”), at a purchase price of $3.38 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively. This Warrant is one of a series of Warrants issued by the Company in connection with a private placement of Common Stock and of like tenor, except as to the number of shares of Common Stock subject thereto (collectively, t
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 5th, 2005 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
This Securities Purchase Agreement, dated on and as of the date set forth on the signature page hereto (this “Agreement”), is made between Senesco Technologies, Inc., a Delaware corporation (the “Company”), the undersigned purchaser(s) (each a “Purchaser” and collectively, the “Purchasers”) and each assignee of a Purchaser who becomes a party hereto.
Placement Agent AgreementPlacement Agent Agreement • May 5th, 2005 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
The undersigned, Senesco Technologies, Inc., a Delaware corporation (the “Company”), hereby agrees (the “Agreement”) with Oppenheimer & Co. Inc. (“Oppenheimer” or “Placement Agent”) as follows:
